Scge Management LP Upped Its Alibaba Group Hldg LTD (BABA) Stake by $22.02 Million; Cam Group Holding A Has Cut Its Position in Horizon Pharma Plc (HZNP) by $563,556

April 17, 2018 - By Clifton Ray

Horizon Pharma Public Limited Company (NASDAQ:HZNP) Logo

Christopher Lyle increased its stake in Alibaba Group Hldg Ltd (BABA) by 58.99% based on its latest 2017Q4 regulatory filing with the SEC. Scge Management Lp bought 128,000 shares as the company’s stock rose 3.18% while stock markets declined. The hedge fund run by Christopher Lyle held 345,000 shares of the business services company at the end of 2017Q4, valued at $59.49 million, up from 217,000 at the end of the previous reported quarter. Scge Management Lp who had been investing in Alibaba Group Hldg Ltd for a number of months, seems to be bullish on the $458.94B market cap company. The stock increased 2.24% or $3.91 during the last trading session, reaching $178.61. About 8.92 million shares traded. Alibaba Group Holding Limited (NYSE:BABA) has risen 68.29% since April 17, 2017 and is uptrending. It has outperformed by 56.74% the S&P500.

Cam Group Holding A decreased its stake in Horizon Pharma Plc (HZNP) by 10.51% based on its latest 2017Q4 regulatory filing with the SEC. Cam Group Holding A sold 40,254 shares as the company’s stock declined 6.58% with the market. The institutional investor held 342,894 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $5.01M, down from 383,148 at the end of the previous reported quarter. Cam Group Holding A who had been investing in Horizon Pharma Plc for a number of months, seems to be less bullish one the $2.28 billion market cap company. The stock increased 4.07% or $0.54 during the last trading session, reaching $13.81. About 1.28 million shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 6.20% since April 17, 2017 and is downtrending. It has underperformed by 17.75% the S&P500.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Horizon Pharma had 62 analyst reports since September 9, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cowen & Co given on Friday, November 10. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by Piper Jaffray on Friday, July 14. Cantor Fitzgerald maintained it with “Buy” rating and $17.0 target in Thursday, August 17 report. Piper Jaffray maintained it with “Buy” rating and $22.0 target in Wednesday, February 28 report. The firm has “Buy” rating given on Monday, December 14 by Mizuho. Cantor Fitzgerald maintained the stock with “Buy” rating in Sunday, April 15 report. The stock has “Buy” rating by Mizuho on Wednesday, April 11. Citigroup reinitiated the stock with “Neutral” rating in Wednesday, January 6 report. The firm has “Buy” rating by Mizuho given on Tuesday, May 3. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by BMO Capital Markets on Monday, August 7.

Investors sentiment increased to 1.04 in 2017 Q4. Its up 0.04, from 1 in 2017Q3. It improved, as 30 investors sold HZNP shares while 53 reduced holdings. 33 funds opened positions while 53 raised stakes. 128.65 million shares or 2.76% less from 132.29 million shares in 2017Q3 were reported. State Board Of Administration Of Florida Retirement Systems holds 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP) or 75,518 shares. Alliancebernstein LP reported 0% stake. 444,796 were accumulated by Prudential Public Limited. Envestnet Asset Management Inc stated it has 2,413 shares or 0% of all its holdings. Quantbot Techs Lp holds 77,245 shares. Barclays Public Limited invested in 364,193 shares. Rhenman Prns Asset Mgmt Ab owns 1.95 million shares for 3.86% of their portfolio. Sterling Ltd Liability owns 91,793 shares for 0.01% of their portfolio. State Common Retirement Fund has 274,401 shares for 0% of their portfolio. Invesco Limited, a Georgia-based fund reported 128,192 shares. Texas-based Hbk Investments LP has invested 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Morgan Stanley reported 495,371 shares. Bank & Trust Of Mellon Corporation, New York-based fund reported 944,020 shares. Martingale Asset Management LP holds 100,972 shares or 0.02% of its portfolio. Piedmont Inv Ltd Llc owns 0.01% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 45,170 shares.

Cam Group Holding A, which manages about $6.92 billion US Long portfolio, upped its stake in Priceline Grp Inc (NASDAQ:PCLN) by 1,934 shares to 109,342 shares, valued at $190.01M in 2017Q4, according to the filing. It also increased its holding in Heron Therapeutics Inc (NASDAQ:HRTX) by 31,600 shares in the quarter, for a total of 131,600 shares, and has risen its stake in Express Scripts Hldg Co (NASDAQ:ESRX).

Horizon Pharma Public Limited Company (NASDAQ:HZNP) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.